Atria Investments LLC Xencor Inc Transaction History

Atria Investments LLC

$7.36 Billion
Q2 2024

A detailed history of Atria Investments LLC transactions in Xencor Inc stock. As of the latest transaction made, Atria Investments LLC holds 14,611 shares of XNCR stock, worth $295,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,611

Holding current value

$295,872

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	$18.21 - $24.5 $266,066 - $357,969	14,611 New	14,611 $276,000
Q2 2019 Aug 09, 2019	BUY	$29.6 - $40.93 $311,362 - $430,542	10,519 New	10,519 $0

Others Institutions Holding XNCR

# of Institutions

204

Shares Held

63.1M

Call Options Held

3.9K

Put Options Held

Black Rock Inc. New York, NY

11.1M
Shares

$225 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.12M
Shares

$185 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

7M
Shares

$142 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$108 Million
3.57% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.96M
Shares

$80.2 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.21B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account